|
Market Closed -
BURSA MALAYSIA
04:50:04 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 0.4350 MYR | -1.14% |
|
-2.25% | -3.33% |
Company Valuation: TMC Life Sciences
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,089 | 888.4 | 1,045 | 1,150 | 749 | 783.8 |
| Change | - | -18.4% | 17.65% | 10% | -34.85% | 4.65% |
| Enterprise Value (EV) 1 | 1,122 | 955.7 | 1,095 | 1,164 | 820.3 | 814 |
| Change | - | -14.83% | 14.63% | 6.23% | -29.51% | -0.77% |
| P/E | 53.9x | 21.5x | 26.7x | 28.3x | 208x | 45.1x |
| PBR | 1.38x | 1.07x | 1.21x | 1.29x | 0.88x | 0.9x |
| PEG | - | 0x | -5.03x | 7.96x | -2.3x | 0x |
| Capitalization / Revenue | 5.42x | 3.64x | 3.35x | 3.32x | 2.17x | 1.99x |
| EV / Revenue | 5.58x | 3.92x | 3.52x | 3.36x | 2.37x | 2.07x |
| EV / EBITDA | 31.1x | 21.4x | 16x | 14.5x | 21.7x | 13.9x |
| EV / EBIT | 43.4x | 29.8x | 23.3x | 20.3x | 67.2x | 26.8x |
| EV / FCF | -17x | -22x | -187x | 35.3x | -29.7x | 18.1x |
| FCF Yield | -5.89% | -4.55% | -0.54% | 2.84% | -3.37% | 5.52% |
| Dividend per Share 2 | 0.002215 | 0.002763 | 0.004199 | 0.004898 | 0.001863 | 0.005763 |
| Rate of return | 0.35% | 0.54% | 0.7% | 0.74% | 0.43% | 1.28% |
| EPS 2 | 0.0116 | 0.0238 | 0.0225 | 0.0233 | 0.00207 | 0.009977 |
| Distribution rate | 19.1% | 11.6% | 18.7% | 21% | 90% | 57.8% |
| Net sales 1 | 201 | 243.8 | 311.6 | 346.4 | 345.6 | 393 |
| EBITDA 1 | 36.02 | 44.63 | 68.43 | 80.28 | 37.81 | 58.47 |
| EBIT 1 | 25.84 | 32.1 | 47.04 | 57.36 | 12.21 | 30.36 |
| Net income 1 | 20.25 | 41.39 | 39.26 | 40.65 | 3.606 | 17.38 |
| Net Debt 1 | 33.45 | 67.3 | 50.36 | 14.1 | 71.33 | 30.15 |
| Reference price 2 | 0.6250 | 0.5100 | 0.6000 | 0.6600 | 0.4300 | 0.4500 |
| Nbr of stocks (in thousands) | 1,741,882 | 1,741,882 | 1,741,882 | 1,741,882 | 1,741,882 | 1,741,882 |
| Announcement Date | 8/24/21 | 8/23/22 | 8/22/23 | 8/21/24 | 8/26/25 | 8/14/26 |
1MYR in Million2MYR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 188M | ||
| 30.86x | 2.89x | 12.93x | 1.42% | 17.2B | ||
| 51.94x | 4.46x | 29.06x | 0.27% | 13.55B | ||
| 19.07x | 2.27x | 10.58x | 0.65% | 11.99B | ||
| 25.63x | 3x | 10.43x | 1.57% | 11.38B | ||
| 85.41x | 7.77x | 31.66x | - | 10.09B | ||
| 24.33x | 1.98x | 15.94x | 0.16% | 9.93B | ||
| 19.48x | 2.83x | 11.66x | 4.15% | 9.56B | ||
| 40.68x | 1.05x | 8.7x | 1.59% | 8.85B | ||
| 12.9x | 1.31x | 7.83x | 2.15% | 7.86B | ||
| Average | 34.48x | 3.06x | 15.42x | 1.5% | 10.06B | |
| Weighted average by Cap. | 34.92x | 3.15x | 15.83x | 1.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 0101 Stock
- Valuation TMC Life Sciences
Select your edition
All financial news and data tailored to specific country editions
















